Menu Menu

News

Topics

Featured

COVID-19 Research Pipeline

STUDIES

Cochrane COVID-19 Study Register

205,745

Registered/ Published

RCTs

covid-nma.com

4,597

Registered

780

Published

SYSTEMATIC REVIEWS

Prospero

7,632

Registered

As at 24 March 2023

Tweets by evidence_aus

FILTERED BY > Media Release Clear filter

Taskforce makes conditional recommendation for use of sotrovimab

26 August, 2021

The National COVID-19 Clinical Evidence Taskforce today published three recommendations on the use of sotrovimab for the treatment of COVID-19 in adults who do not require oxygen and who have risk factors for disease progression. These are the first recommendations from the Taskforce to use a drug to treat patients with mild illness. The Taskforce updated the sotrovimab recommendation after...

Saving lives safely: Taskforce issues guidance on CPR during the pandemic

22 October, 2020

Healthcare workers and trained first aid responders are being urged not to delay commencing cardiopulmonary resuscitation (CPR) because of the COVID-19 pandemic. The National COVID-19 Clinical Evidence Taskforce,...

Taskforce makes recommendation for use of dexamethasone for patients receiving oxygen

The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of dexamethasone for the treatment of people with COVID-19 who are receiving oxygen or mechanical ventilation. The...

Statement from the National COVID-19 Clinical Evidence Taskforce on media release of results of dexamethasone arm of the UK RECOVERY Trial

The National COVID-19 Clinical Evidence Taskforce (the Taskforce) has noted the media release of preliminary results from the dexamethasone arm of the RECOVERY (Randomised Evaluation of COVid-19 thERapY)...

Taskforce issues first recommendation for drug treatment for COVID-19

The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of remdesivir in treatment of people with COVID-19. The Taskforce is comprised of 28 peak health...